Company Search:
Advanced Search
Sponsored Links
Infant Bacterial Therapeutics AB Company Snapshot
Infant Bacterial Therapeutics AB operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Infant Bacterial Therapeutics AB with three other companies in this sector in Sweden: Oasmia Pharmaceutical AB (2017 sales of 172,000.00 Swedish Kronor [US$18,584.60 ] of which 100% was Sale of Necessities), Irlab Therapeutics Ab (109,000.00 Swedish Kronor [US$11,777.45 ] ), and Index Pharmaceuticals Holding Ab (113,000.00 Swedish Kronor [US$12,209.65 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Infant Bacterial Therapeutics AB
  Stock Performance Chart for Infant Bacterial Therapeutics AB
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 169.00
(Figures in Swedish Kronor)
1 Week -2.0%   13 Weeks 11.6%  
4 Weeks 21.1%   52 Weeks 48.2%  
Infant Bacterial Therapeutics AB Key Data:
  Ticker: IBT B Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 238,000
(Year Ending Jan 2018).
Employees: N/A
  Currency: Swedish Kronor Market Cap: 1,897,225,096
  Fiscal Yr Ends: December Shares Outstanding: 11,226,184
  Share Type: Aktie Closely Held Shares: 969,603
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.